Ron Beller and Manal Mehta launch Branch Hill Capital

September 23rd, 2010
| More
Ron Beller has recently launched Branch Hill Capital, a new hedge fund management firm based in San Francisco. Mr. Beller had previously founded Peloton Partners in 2005 with fellow Goldman Sachs veteran Geoff Grant, but the asset-backed security focused hedge fund firm went bust in February 2008. According to the Wall Street Journal, after the fund’s dissolution Mr. Grant founded Grant Capital Partners, a global macro hedge fund manager that currently oversees $350 million. Mr. Beller’s re-launch also follows similar reincarnations of funds that imploded during the financial crisis and credit crunch, including Jim Pallotta’s recent launch of the
Raptor Evolution Fund.

Mr. Beller founded Branch Hill Capital with Manal Mehta, a former colleague at Peloton Partners, and the pair are currently managing $40 million of their own funds with plans to open the fund to external investment before the end of the year. Branch Hill follows a deep-value special-situations strategy with listed stocks and credit-default swaps but no leverage.
For Detailed Investor Profiles on these Investors, click below:
Branch Hill Capital
Grant Capital Partners*
Related People: Geoff Grant; Manal Mehta; Ron Beller
Related Entities: Branch Hill Capital LLC; Peloton Partners*; Peloton Partners*; Branch Hill Opportunity Fund LP; Grant Capital
Related Article Tags: Investment Management, Fund Manager and General Financial News; Hedge Fund Jobs, Hirings and Firings; Hedge Fund Launches and Hedge Fund Closings

More Recent Headlines

Capstone veteran Steven Yashar founds Cosyne Capital Management

Paul Tudor Jones is Not Making Investors Any Money

Shareholder Activist Ramius Capital finalizes agreement with Aviat, pressures SeaChange

Ivaldi Capital, backed by Citigroup, raises $500mm for launch

George Soros warns investors away from the ultimate gold bubble

Is Coal the New Black Gold?

Richard Grubman and Robert Rubin leave hedge fund posts

York Capital Management gets $425 million for non-controlling minority stake

Jim Pallotta takes a mulligan, launches Raptor Evolution Fund

Ramius makes another offer for Cypress Bioscience